The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
Open accessAbstract
In this report we have investigated macrophage (M phi) activity and tumor necrosis factor alpha (TNF-alpha) production during graft-vs.-host disease (GVHD). TNF-alpha production by M phi requires two signals: priming of M phi by interferon followed by triggering of TNF-alpha production and release by lipopolysaccharide (LPS). The state of M phi activation was examined in nonirradiated B6AF1 recipient mice injected with either 60 x 10(6) (acute GVHD) or 30 x 10(6) (nonlethal GVHD) parental B6 lymphoid cells. During the early phase of acute GVHD, administration of normally sublethal amounts of LPS-triggered release of significant amounts of TNF-alpha into the serum resulting in death of the animals within 36 h. Normal animals treated with the same dose of LPS neither died nor produced detectable amounts of serum TNF-alpha. In vitro studies demonstrated that M phi were primed during GVHD. The level of M phi priming was greater during acute GVHD than nonlethal GVHD since 100-fold less LPS was required to trigger killing of a TNF-alpha-sensitive cell line by M phi from acute GVHD animals. The amount of TNF-alpha released into the serum after LPS injection increased during the course of the GVHD and was significantly greater in acute GVH-reactive mice. Endogenous LPS was detected in the serum of acute GVH-reactive animals coincident with the onset of mortality. The data provide evidence that during GVHD M phi are primed as a result of the allogeneic reaction and that endogenous LPS therefore triggers M phi production of TNF-alpha resulting in the symptoms characteristic of acute GVHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Further improvements in the plaque technique for detecting single antibody-forming cells.
Cunningham, A. J., & Szenberg, A. (1968) · PubMed · Cited by 2,153
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin
Gordon, J. R., & Galli, S. J. (1990) · Nature · doi:10.1038/346274a0 · Cited by 985
Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.984 · Cited by 821
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
Beutler, B. A., Milsark, I. W., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3972 · Cited by 763
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
Flick, D. A., & Gifford, G. E. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90147-9 · Cited by 745
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A., & Pasagian, A. (1988) · Science · doi:10.1126/science.3259727 · Cited by 597
Piguet, P. F., Grau, G. E., Allet, B., & Vassalli, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1280 · Cited by 584
Holler, E., Kolb, H., Moller, A., Kempeni, J., Liesenfeld, S., Pechumer, H., Lehmacher, W., Ruckdeschel, G., Gleixner, B., & Riedner, C. (1990) · Blood · doi:10.1182/blood.v75.4.1011.1011 · Cited by 577
Recognition and plasma clearance of endotoxin by scavenger receptors
Hampton, R. Y., Golenbock, D. T., Penman, M., Krieger, M., & Raetz, C. R. H. (1991) · Nature · doi:10.1038/352342a0 · Cited by 524
A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
Torti, F. M., Dieckmann, B., Beutler, B., Cerami, A., & Ringold, G. M. (1985) · Science · doi:10.1126/science.3839597 · Cited by 518
Pace, J. L., Russell, S. W., Torres, B. A., Johnson, H. M., & Gray, P. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2011 · Cited by 442
Storb, R., Prentice, R. L., Buckner, C. D., Clift, R. A., Appelbaum, F., Deeg, J., Doney, K., Hansen, J. A., Mason, M., Sanders, J. E., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302103080602 · Cited by 431
Evidence that tumor necrosis factor has an important role in antibacterial resistance.
Havell, E. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.2894 · Cited by 405
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor)
Männel, D. N., Moore, R. N., & Mergenhagen, S. E. (1980) · Infection and Immunity · doi:10.1128/iai.30.2.523-530.1980 · Cited by 390
Antiviral effects of recombinant tumour necrosis factor in vitro
Mestan, J., Digel, W., Mittnacht, S., Hillen, H., Blohm, D., Möller, A., Jacobsen, H., & Kirchner, H. (1986) · Nature · doi:10.1038/323816a0 · Cited by 383
Cuturi, M. C., Murphy, M., Costa-Giomi, M. P., Weinmann, R., Perussia, B., & Trinchieri, G. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.6.1581 · Cited by 360
Bekkum, D. W. V., Roodenburg, J., Heidt, P. J., & Waaij, D. V. D. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.401 · Cited by 330
Djeu, J. Y., Blanchard, D. K., Halkias, D., & Friedman, H. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.9.2980 · Cited by 284
Beutler, B., Tkacenko, V, Milsark, I., Krochin, N., & Cerami, A. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.5.1791 · Cited by 235
Mortality and Gross Pathology of Secondary Disease in Germfree Mouse Radiation Chimeras
Jones, J. M., Wilson, R., & Bealmear, P. M. (1971) · Radiation Research · doi:10.2307/3573066 · Cited by 210
Anticachectin/tumor necrosis factor‐α antibodies attenuate development of cachexia in tumor models
Sherry, B. A., Gelin, J., Fong, Y., Marano, M., Wei, H., Cerami, A., Lowry, S. F., Lundholm, K. G., & Moldawer, L. L. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.8.2721856 · Cited by 207
Gifford, G. E., & Lohmann‐Matthes, M. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/78.1.121 · Cited by 202
Cerami, A., Ikeda, Y., Le Trang, N., Hotez, P. J., & Beutler, B. (1985) · Immunology Letters · doi:10.1016/0165-2478(85)90165-8 · Cited by 202
Pace, J. L., & Russell, S. W. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.5.1863 · Cited by 170
Mowat, A. M. (1989) · PubMed Central · Cited by 170
Pace, J. L., Russell, S. W., LeBlanc, P. A., & Murasko, D. M. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.2.977 · Cited by 149
Peters, P. M., Ortaldo, J. R., Shalaby, M. R., Svedersky, L. P., Nedwin, G. E., Bringman, T. S., Hass, P. E., Aggarwal, B. B., Herberman, R. B., Goeddel, D. V., et al. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.8.2592 · Cited by 146
Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice
Owens, W. E., & Berg, R. D. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.461-467.1980 · Cited by 144
Role of Bacterial Microflora in Development of Intestinal Lesions From Graft-Versus-Host Reaction
van Bekkum, D. W., & Knaan, S. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/58.3.787 · Cited by 136
Munford, R. S., Hall, C. L., Lipton, J. M., & Dietschy, J. M. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110684 · Cited by 122
ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION
Niederwieser, D. W., HEROLD, M., Woloszczuk, W., Aulitzky, W. E., Meister, B., Tilg, H., GASTL, G., Bowden, R., & HUBER, C. (1990) · Transplantation · doi:10.1097/00007890-199010000-00019 · Cited by 106
Adenosine phosphorylase-mediated nucleoside toxicity
McGarrity, G. J., & Carson, D. A. (1982) · Experimental Cell Research · doi:10.1016/0014-4827(82)90333-0 · Cited by 95
Gamma‐Interferon is Produced by CD3+ and CD3‐ Lymphocytes
Sandvig, S., Laskay, T., Andersson, J., LEY, M. D., & Andersson, U. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb00516.x · Cited by 61
GRAFT-VERSUS-HOST REACTIONS IN THE BEIGE MOUSE
Ghayur, T., Seemayer, T. A., Kongshavn, P. A. L., et al. (1987) · Transplantation · doi:10.1097/00007890-198708000-00017 · Cited by 60
Self-citationGhayur, T., Seemayer, T. A., & Lapp, W. S. (1988) · Transplantation · doi:10.1097/00007890-198803000-00017 · Cited by 26
Self-citation
Cited by
Cooke, K., Kobzik, L., Martin, T., Brewer, J., Delmonte, J. J., Crawford, J., & Ferrara, J. (1996) · Blood · doi:10.1182/blood.v88.8.3230.bloodjournal8883230 · Cited by 963
Advances in graft-versus-host disease biology and therapy
Blazar, B. R., Murphy, W. J., & Abedi, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3212 · Cited by 880
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., & Ferrara, J. L. M. (1997) · Blood · doi:10.1182/blood.v90.8.3204 · Cited by 832
Neuroinflammation: The role and consequences
Lyman, M., Lloyd, D. G., Ji, X., Vizcaychipi, M. P., & Ma, D. (2014) · Neuroscience Research · doi:10.1016/j.neures.2013.10.004 · Cited by 730
Hill, G. R., & Ferrara, J. L. M. (2000) · Blood · doi:10.1182/blood.v95.9.2754.009k25_2754_2759 · Cited by 715
Metadata
- Authors
- Nestel, F. P., Price, K. S., Seemayer, T. A., & Lapp, W. S.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1992-02-01
- Volume
- 175
- Issue
- 2
- Pages
- 405-413
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2120428769
- Cited by
- 365
- References
- 40
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.